Santa Helena

Santa Helena is a prominent Brazilian pharmaceutical company that operates as a key subsidiary of Hypera Pharma, the largest pharmaceutical group in Brazil. The company specializes in the development, manufacturing, and commercialization of a vast portfolio of generic medicines and over-the-counter (OTC) products. Based in the industrial hub of Anápolis, Goiás, Santa Helena utilizes large-scale manufacturing facilities to produce essential medications across multiple therapeutic areas, including pain management, respiratory health, and anti-infectives. Since its acquisition by Hypera (formerly Hypermarcas) in 2007, the company has been a cornerstone of the group's strategy to provide affordable healthcare solutions to the Brazilian market. Its products are widely distributed through retail pharmacies and institutional channels throughout Latin America's largest economy.